secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fuse Medical, Inc. (FZMD)
CIK:        0000319016
Form:       8-K
Filed at:   2023-04-18T23:59:59+00:00
Accession:  0001564590-23-005823
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fuse Medical reports FY 2022 net income of $3.1M, swing from prior-year loss; revenue down 9%
--------------------------------------------------------------------------------

- Net revenue $18.6M (-9% YoY); gross profit margin improved to 62% from 58%.
- Net income of $3.1M vs net loss of $1.59M in FY 2021, a swing of $4.69M.
- Adjusted EBITDA loss narrowed to ~$1.0M from ~$2.0M (improvement of ~50%).
- SG&A down 7% to $6.5M; commissions expense down 20% to $5.7M.
- CEO Reeg: focus in 2023 on design, development, commercialization, and expanding direct sales force.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/319016/000156459023005823/0001564590-23-005823-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/319016/000156459023005823/fzmd-8k_20230414.htm
  HTML page:      https://secwatch.observer/filing/0001564590-23-005823

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer